Change in metabolic tumor activity on F-18-FDG PET after a single dose of cetuximab to predict for treatment benefit, PFS, and OS in patients with advanced colorectal cancer.

Erik Jacobus Van Helden, Catharina Wilhelmina Menke, Eline Boon, Suzanne van Es, Marc C. Huisman, Derk Jan De Groot, Ronald Boellaard, Carla M. L. - Van Herpen, Elisabeth De Vries, Otto S. Hoekstra, Henk M. W. Verheul

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
JournalJournal of Clinical Oncology
Publication statusPublished - 20 May 2017

Cite this